S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILITY AND ENHANCES CLONOGENIC POTENTIAL OF CHRONIC MYELOID LEUKEMIA (CML) PROGENITORS

S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILITY AND ENHANCES CLONOGENIC POTENTIAL OF CHRONIC MYELOID LEUKEMIA (CML) PROGENITORS

Bibliographic Details
Main Authors:	M. Mancini, S. De Santis, C. Monaldi, S. Bruno, F. Castagnetti, G. Gugliotta, A. Iurlo, M. Cerrano, S. Galimberti, S. Balducci, F. Stagno, G. Rosti, M. Cavo, S. Soverini
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000843500.89390.73

Similar Items

Current treatment approaches in CML
by: Fausto Castagnetti, et al.
Published: (2019-06-01)

P993: SETD2 IS A BONA FIDE TUMOR SUPPRESSOR IN SYSTEMIC MASTOCYTOSIS
by: M. Mancini, et al.
Published: (2022-06-01)

P698: BOSUTINIB DOSE OPTIMIZATION IN THE SECOND-LINE TREATMENT OF ELDERLY CML PATIENTS: EXTENDED 3-YEAR FOLLOW-UP AND FINAL RESULTS OF THE BEST STUDY
by: F. Castagnetti, et al.
Published: (2022-06-01)

Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights
by: Miriam Iezza, et al.
Published: (2023-06-01)

SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT
by: Cecilia Monaldi, et al.
Published: (2021-06-01)

Clonogenic Assay
by: Xiaodong Yang
Published: (2012-05-01)

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study
by: Gabriele Gugliotta, et al.
Published: (2022-04-01)

The role of SETD3 in the immune system
by: Bunjamin, Maegan
Published: (2020)

CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
by: Lodovico Balducci
Published: (2014-05-01)

The EV71 2A protease occupies the central cleft of SETD3 and disrupts SETD3-actin interaction
by: Xiaopan Gao, et al.
Published: (2024-05-01)

Functional characterization and physiological significance of SETD3
by: Chia, Shyh Jenn
Published: (2017)

S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
by: Nikola Čuřík, et al.
Published: (2023-08-01)

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP
by: Michele Baccarani, et al.
Published: (2019-12-01)

Clonogenicity: holoclones and meroclones contain stem cells.
by: Charlotte M Beaver, et al.
Published: (2014-01-01)

The Structure, Activity, and Function of the SETD3 Protein Histidine Methyltransferase
by: Apolonia Witecka, et al.
Published: (2021-10-01)

TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2014-01-01)

Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure
by: Francesca Palandri, et al.
Published: (2009-12-01)

Proteolytic Activities of Enterovirus 2A Do Not Depend on Its Interaction with SETD3
by: Xiaoyao Yang, et al.
Published: (2022-06-01)

Examining prestructured β-actin peptides as substrates of histidine methyltransferase SETD3
by: Marijn N. Maas, et al.
Published: (2024-11-01)

A Flow Cytometric Clonogenic Assay Reveals the Single-Cell Potency of Doxorubicin
by: Kulkarni, Chethana, et al.
Published: (2017)

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party
by: Gianantonio Rosti, et al.
Published: (2007-01-01)

Spatiotemporal role of SETD2-H3K36me3 in murine pancreatic organogenesis
by: Ping Lu, et al.
Published: (2024-02-01)

The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis
by: Zhangguo Chen, et al.
Published: (2013-05-01)

EAS 152(3) - KEKEKUATAN BAHAN APRIL 03
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2003)

EAS 152(3) - KEKUATAN BAHAN MAC 05
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2005)

EAS 152-3 - STRENGTH OF MATERIALS APRIL 08.
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2008)

EAS 152-3 STRENGTHS OF MATERIAL APRIL 07.
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2007)

EAS152-3 - STRENGTH OF MATERIALS JUNE 2012
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2012)

EAS152/3 - KEKUATAN BAHAN. MAC 2004
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2004)

EAS152/3 - KEKUATAN BAHAN. APRIL 2002
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2002)

EAS152/3 - KEKUATAN BAHAN. APRIL 2004
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2004)

EAS 152-3 - STRENGTH OF MATERIALS JUN 09.
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2009)

EAS152-3 -STRENGTH OF MATERIALS JUN 2008
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2008)

Differences of Clonogenic Mesenchymal Stem Cells on Immunomodulation of Lymphocyte Subsets
by: Pascual Martínez-Peinado, et al.
Published: (2018-01-01)

The methyltransferase SETD3 regulates mRNA alternative splicing through interacting with hnRNPK
by: Yue-Yu Kong, et al.
Published: (2024-12-01)

Glycogene Expression Profile of Human Limbal Epithelial Cells with Distinct Clonogenic Potential
by: Damien Guindolet, et al.
Published: (2022-05-01)

Samohodna haubica 152 mm 2S3 AKACIJA, Military Parade, 1996
by: M. P.
Published: (1996-08-01)

The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling
by: Hye-Min Jeon, et al.
Published: (2023-11-01)

Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation
by: Simona Bernardi, et al.
Published: (2019-05-01)

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
by: Parker, H, et al.
Published: (2016)